● Recruiting

Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer

Condition: Localized Breast Cancer · Sponsor: Centre Antoine Lacassagne

PhasePhase 2

Planned participants40

Who can joinFemale, 65 Years to no upper limit

Healthy volunteersNo

About this study

Phase II study; open recruitment, multicentrique. The aim of this clinical research is to evaluate faisability and toxicity of the per-operative radiotherapy using PAPILLON + TM device for localized breast cancers patients over 65 years.

This description comes directly from the study's public registry record.

Talk to the study team

Frédérique JACQUINOT · 04 92 03 10 24 · drci-promotion@nice.unicancer.fr

Always discuss trial participation with your own doctor first.

Locations (2)

Pôle Santé République	Clermont-Ferrand, France	Not Yet Recruiting
Centre Antoine Lacassagne	Nice, France	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04680715